Uncovering the relationship between macroH2A1.1 depletion and defective ribosomal biogenesis in HSCs/HPCs provides a critical link between this epigenetic regulator and the molecular pathologies typical of MDS. This evidence concerns the gene MACROH2A1 and myelodysplastic syndrome.